Results 201 to 210 of about 239,193 (267)
Unexplained Coma and Sudden Death in Psychiatric Patients Due to Self-Induced Water Intoxication: Clinical Insights and Autopsy Findings From Two Fatal Cases. [PDF]
Pini S+6 more
europepmc +1 more source
Kidney status and events preceding death in heart failure: A real‐world nationwide study
Abstract Aims Chronic kidney disease is a frequent comorbidity in heart failure (HF) patients, affecting prognosis and mortality. This study investigates the relationship between kidney function and adverse kidney events preceding death in HF patients. Methods and results We analysed registry data of HF patients who died between 2014 and 2021, with at ...
Deewa Zahir Anjum+9 more
wiley +1 more source
Sudden cardiac death after coronary artery bypass graft surgery and role of antiplatelet therapy. [PDF]
Ch IA+13 more
europepmc +1 more source
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta‐analysis. Clonal haematopoiesis and heart failure: a meta‐analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure. [Correction added on 15 March 2025, after first online publication: The graphical image was corrected in ...
Paschalis Karakasis+8 more
wiley +1 more source
Anomalous origin of the left main coronary artery in a 62‑year‑old woman: a case report and review of the literature. [PDF]
Safariyan M+8 more
europepmc +1 more source
Abstract Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision‐making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices
Biykem Bozkurt+15 more
wiley +1 more source
Particular Aspects of Cardiac Rhythm Disorders in Pediatric Patients. [PDF]
Moraru I+6 more
europepmc +1 more source
Abstract Aims Sudden cardiac death (SCD) is a prevalent cause of mortality among patients with cardio‐kidney‐metabolic (CKM) diseases. Mineralocorticoid receptor antagonists (MRAs) reduce the risk of SCD in patients with left ventricular dysfunction, but it is unclear if similar effects are expected across different CKM risk populations irrespective of
Pedro Marques+2 more
wiley +1 more source